Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Med Chem ; 28(9): 1285-91, 1985 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-4032431

RESUMEN

A series of 4,4-disubstituted tetrahydro- and 4,4-disubstituted hexahydro-3H-pyrido[1,2-c]pyrimidin-3-ones (4 and 5, respectively) were prepared from 2-aryl-2-(2-piperidinyl)-4-[N,N-bis (1-methylethyl)amino] butanamides (2). Individual racemates of the piperidinyl amides 2 were converted to pure racemic diaza bicyclic compounds that were evaluated for antiarrhythmic activity in the Harris dog model and anticholinergic activity in a muscarinic receptor binding assay. Selected compounds were subsequently evaluated for hemodynamic effects in anesthetized dogs where blood pressure depression and negative inotropic activity were assessed. Of this group, 4a (R = CH3) and 5a (R = CH3) showed the most favorable pharmacological profiles; the former compound was chosen for toxicity testing over the latter due to its lack of noncompetitive inhibition of acetylcholine-induced contractions of guinea pig ileum segments. Clinical evaluation is now under way.


Asunto(s)
Arritmias Cardíacas/tratamiento farmacológico , Pirimidinonas/uso terapéutico , Animales , Presión Sanguínea/efectos de los fármacos , Encéfalo/metabolismo , Fenómenos Químicos , Química , Depresión Química , Modelos Animales de Enfermedad , Perros , Femenino , Cobayas , Corazón/efectos de los fármacos , Espectroscopía de Resonancia Magnética , Masculino , Contracción Miocárdica/efectos de los fármacos , Piridinas/síntesis química , Piridinas/farmacología , Piridinas/uso terapéutico , Pirimidinonas/síntesis química , Pirimidinonas/farmacología , Quinuclidinil Bencilato/metabolismo , Ratas , Receptores Muscarínicos/efectos de los fármacos , Receptores Muscarínicos/metabolismo , Difracción de Rayos X
2.
Nat Nanotechnol ; 3(6): 327-31, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18654541

RESUMEN

Polymer-based composites were heralded in the 1960s as a new paradigm for materials. By dispersing strong, highly stiff fibres in a polymer matrix, high-performance lightweight composites could be developed and tailored to individual applications. Today we stand at a similar threshold in the realm of polymer nanocomposites with the promise of strong, durable, multifunctional materials with low nanofiller content. However, the cost of nanoparticles, their availability and the challenges that remain to achieve good dispersion pose significant obstacles to these goals. Here, we report the creation of polymer nanocomposites with functionalized graphene sheets, which overcome these obstacles and provide superb polymer-particle interactions. An unprecedented shift in glass transition temperature of over 40 degrees C is obtained for poly(acrylonitrile) at 1 wt% functionalized graphene sheet, and with only 0.05 wt% functionalized graphene sheet in poly(methyl methacrylate) there is an improvement of nearly 30 degrees C. Modulus, ultimate strength and thermal stability follow a similar trend, with values for functionalized graphene sheet- poly(methyl methacrylate) rivaling those for single-walled carbon nanotube-poly(methyl methacrylate) composites.


Asunto(s)
Carbono/química , Cristalización/métodos , Membranas Artificiales , Nanoestructuras/química , Nanoestructuras/ultraestructura , Nanotecnología/métodos , Polimetil Metacrilato/química , Sustancias Macromoleculares/química , Ensayo de Materiales , Conformación Molecular , Tamaño de la Partícula , Polímeros/química , Propiedades de Superficie
3.
Phys Rev Lett ; 96(1): 018301, 2006 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-16486526

RESUMEN

Surfactant micelles form oriented arrays on crystalline substrates although registration is unexpected since the template unit cell is small compared to the size of a rodlike micelle. Interaction energy calculations based on molecular simulations reveal that orientational energy differences on a molecular scale are too small to explain matters. With atomic force microscopy, we show that orientational ordering is a dynamic, multimolecule process. Treating the cooperative processes as a balance between van der Waals torque on a large, rodlike micellar assembly and Brownian motion shows that orientation is favored.

4.
J Cardiovasc Pharmacol ; 9(1): 57-64, 1987 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2434795

RESUMEN

The in vitro electrophysiological properties of a new class I antiarrhythmic agent, SC-36602, were evaluated by recording action potentials (APs) from guinea pig papillary muscle. SC-36602 and its (+) and (-) enantiomers (10(-6)-10(-4) M) caused a concentration- and only slight frequency-dependent depression of Vmax (maximum rate of rise of the AP). At stimulation rates of 30, 60, 120, and 200 pulses/min, SC-36602 (10(-4) M) reduced Vmax to 64 +/- 2.2, 62 +/- 2.8, 60 +/- 2.4, and 58 +/- 2.7% of control, respectively, and significantly shortened effective refractory period (ERP) (20-40%). The rate constants for onset of block of Vmax during trains of stimuli at 1 or 3.3 Hz were similar (approximately 0.2 AP-1). Slow recovery from Vmax block following a stimulus train recorded in tissue depolarized by 10 mM [K+]o Tyrode's solution was enhanced following exposure to SC-36602. The normalized relationship between Vmax and membrane potential was shifted 3 and 12 mV in the hyperpolarizing direction at stimulation frequencies of 0.2 and 1 Hz, respectively. These results suggest that SC-36602 would preferentially depress conduction in depolarized tissue in vivo.


Asunto(s)
Antiarrítmicos/farmacología , Corazón/efectos de los fármacos , Pirimidinonas/farmacología , Potenciales de Acción/efectos de los fármacos , Animales , Relación Dosis-Respuesta a Droga , Electrofisiología , Cobayas , Potenciales de la Membrana/efectos de los fármacos , Potasio/farmacología , Estereoisomerismo
5.
Artículo en Inglés | MEDLINE | ID: mdl-2887384

RESUMEN

1. Histologic and metabolic changes take place in livers of rooster receiving challenges consisting of acute doses of estrone. 2. During initial Growth and Redifferentiation livers rapidly increase in size by division of hepatocytes within most lobules, changing from cordlike to acinar configurations. 3. No new lobules appear and degeneration of some cells within lobules takes place even as cell divisions predominate. 4. Cells within lobules assume secretory features. 5. Vitellogenins, very low density lipoproteins, calcium and alkaline phosphatase increase greatly in plasma. 6. Within 35-40 days of cessation of estrogen, livers have returned to near normal sizes and plasmas exhibit normal parameters.


Asunto(s)
Estrona/toxicidad , Hígado/patología , Fosfatasa Alcalina/sangre , Animales , Apolipoproteínas/sangre , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Pollos , Replicación del ADN/efectos de los fármacos , Hiperplasia , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Fosvitina/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA